Skip to content

A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.

A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.

A Stanford-designed computer algorithm helps doctors predict the lifespan of patients with metastatic cancer by looking for clues in their own exam notes.

A Stanford-designed computer algorithm helps doctors predict the lifespan of patients with metastatic cancer by looking for clues in their own exam notes.

Published on

In a new study, a team of researchers has examined the relationship between protein binding to DNA and the development of cancer.

In a new study, a team of researchers has examined the relationship between protein binding to DNA and the development of cancer.

Cancerous tumors cause disease in two ways: they grow and spread. But a new immune therapy approach may be able to target both problems simultaneously.

Cancerous tumors cause disease in two ways: they grow and spread. But a new immune therapy approach may be able to target both problems simultaneously.

Published on

A better understanding of how nanoparticles move from the bloodstream into a tumor could eventually lead to more effective cancer treatment.

A better understanding of how nanoparticles move from the bloodstream into a tumor could eventually lead to more effective cancer treatment.

Published on

Hiding mRNA messages in CARTs — positively charged degradable vehicles —smuggles them across the cell membrane and can 'vaccinate' against cancer in mice.

Hiding mRNA messages in CARTs — positively charged degradable vehicles —smuggles them across the cell membrane and can 'vaccinate' against cancer in mice.

Published on

Mapping the geography of the immune response in triple negative breast cancers predicts patient survival and sheds light onto new aspects of tumor biology.

Mapping the geography of the immune response in triple negative breast cancers predicts patient survival and sheds light onto new aspects of tumor biology.

Published on

The true driver mutations of cancer are almost always common to all metastases in an individual, according to a Stanford scientist and other researchers.

The true driver mutations of cancer are almost always common to all metastases in an individual, according to a Stanford scientist and other researchers.

Published on

In this piece, adapted from Months to Years, mother Giulianna Nenna compares her daughter, who has a brain tumor, to her great-grandmother.

In this piece, adapted from Months to Years, mother Giulianna Nenna compares her daughter, who has a brain tumor, to her great-grandmother.

After her older sister died from cancer, 25-year-old Jacqueline Genovese took over care for her children, a 2-year-old and a 4-year-old.

After her older sister died from cancer, 25-year-old Jacqueline Genovese took over care for her children, a 2-year-old and a 4-year-old.